Trials / Conditions / Refractory Indolent Adult Non-Hodgkin Lymphoma
Refractory Indolent Adult Non-Hodgkin Lymphoma
4 registered clinical trials studyying Refractory Indolent Adult Non-Hodgkin Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy NCT04703686 | The Lymphoma Academic Research Organisation | Phase 2 |
| Active Not Recruiting | An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That H NCT04447716 | Thomas Jefferson University | Phase 1 |
| Unknown | CAR-T Cells in Treating Patients With Relapsed or Refractory NHL NCT04626739 | Hebei Senlang Biotechnology Inc., Ltd. | EARLY_Phase 1 |
| Completed | Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patient NCT03019640 | M.D. Anderson Cancer Center | Phase 2 |